Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127032671 | 12703267 | 1 | I | 20160718 | 20160826 | 20160831 | 20160831 | EXP | FR-EISAI MEDICAL RESEARCH-EC-2016-019816 | EISAI | 80.00 | YR | F | Y | 0.00000 | 20160831 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127032671 | 12703267 | 1 | PS | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | 20973 | 20 | MG | TABLET | QD | |||||||
| 127032671 | 12703267 | 2 | I | TARDYFERON | FERROUS SULFATE | 1 | Oral | 20973 | 40 | MG | TABLET | BID | |||||||
| 127032671 | 12703267 | 3 | C | SPECIAFOLDINE | FOLIC ACID | 1 | Unknown | 0 | 5 | MG | UNKNOWN | ||||||||
| 127032671 | 12703267 | 4 | C | BROMAZEPAN | 2 | Unknown | 0 | 3 | MG | UNKNOWN | |||||||||
| 127032671 | 12703267 | 5 | C | CANDESARTAN | CANDESARTAN | 1 | Unknown | 0 | 32 | MG | UNKNOWN | ||||||||
| 127032671 | 12703267 | 6 | C | CLONIDINE. | CLONIDINE | 1 | Unknown | 0 | .15 | MG | UNKNOWN | ||||||||
| 127032671 | 12703267 | 7 | C | DUOPLAVIN | ASPIRINCLOPIDOGREL | 1 | Unknown | 0 | 1 | DF | UNKNOWN | ||||||||
| 127032671 | 12703267 | 8 | C | DULOXETINE. | DULOXETINE | 1 | Unknown | 0 | 60 | MG | UNKNOWN | ||||||||
| 127032671 | 12703267 | 9 | C | EZETIMIBE. | EZETIMIBE | 1 | Unknown | 0 | 10 | MG | UNKNOWN | ||||||||
| 127032671 | 12703267 | 10 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 0 | 40 | MG | UNKNOWN | ||||||||
| 127032671 | 12703267 | 11 | C | INDAPAMIDE. | INDAPAMIDE | 1 | Unknown | 0 | 1.5 | MG | UNKNOWN | ||||||||
| 127032671 | 12703267 | 12 | C | METFORMINE | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | 850 | MG | UNKNOWN | ||||||||
| 127032671 | 12703267 | 13 | C | NEBIVOLOL. | NEBIVOLOL | 1 | Unknown | 0 | 5 | MG | UNKNOWN | ||||||||
| 127032671 | 12703267 | 14 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | 0 | 500 | MG | UNKNOWN | ||||||||
| 127032671 | 12703267 | 15 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | 0 | 10 | MG | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127032671 | 12703267 | 1 | Prophylaxis |
| 127032671 | 12703267 | 2 | Mineral supplementation |
| 127032671 | 12703267 | 3 | Product used for unknown indication |
| 127032671 | 12703267 | 4 | Product used for unknown indication |
| 127032671 | 12703267 | 5 | Product used for unknown indication |
| 127032671 | 12703267 | 6 | Product used for unknown indication |
| 127032671 | 12703267 | 7 | Product used for unknown indication |
| 127032671 | 12703267 | 8 | Product used for unknown indication |
| 127032671 | 12703267 | 9 | Product used for unknown indication |
| 127032671 | 12703267 | 10 | Product used for unknown indication |
| 127032671 | 12703267 | 11 | Product used for unknown indication |
| 127032671 | 12703267 | 12 | Product used for unknown indication |
| 127032671 | 12703267 | 13 | Product used for unknown indication |
| 127032671 | 12703267 | 14 | Product used for unknown indication |
| 127032671 | 12703267 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127032671 | 12703267 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127032671 | 12703267 | Anaemia | |
| 127032671 | 12703267 | Drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |